The recall affects batch number V2500425, which contains 81,872 packs of Sertraline. The error occurred during the secondary packaging process of blister strips into cartons. Both Sertraline and Citalopram are selective serotonin reuptake inhibitors (SSRIs) commonly used to treat depression and anxiety.

Dr. Alison Cave from the Medicines and Healthcare products Regulatory Agency (MHRA) advised patients who received the affected batch to check their medication carefully. She stated, “If you have been prescribed Sertraline 100mg tablets and have received batch number V2500425, please check the carton contains the right medication.”

Patients who mistakenly took Citalopram should seek medical advice immediately. Dr. Cave warned that these patients may experience heightened serotonergic side effects. These can include nausea, headache, sleep changes, and mild anxiety.

This recall highlights the importance of accurate packaging in pharmaceutical products. In 2019, more than 16.7 million prescriptions of Sertraline were issued in England alone. The potential consequences of medication errors can be severe for individuals relying on these medications for mental health treatment.

The post Antidepressants recall appeared first on News Casino.